We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current AVBP market cap is 903.08M. The company's latest EPS is USD -2.0575 and P/E is -13.31.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -23.12M | -20.67M | -25.7M | -24.23M |
| Net Income | -21.19M | -17.42M | -21.87M | -20.56M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 |
| Operating Income | -36.91M | -74.59M |
| Net Income | -36.91M | -69.33M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | |||
| Total Assets | 163.1M | 327.84M | 308.86M | 292.71M |
| Total Liabilities | 11.8M | 10.12M | 12.2M | 15.22M |
| Total Equity | -153.19M | 317.72M | 296.66M | 277.49M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 182.83M | 163.1M |
| Total Liabilities | 8.37M | 11.8M |
| Total Equity | -85.11M | -153.19M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | |||
| Operating | -55.84M | -18.63M | -37.72M | -54.06M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 42.86M | 185.63M | 186M | 186.53M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Operating | -43.63M | -55.84M |
| Investing | N/A | N/A |
| Financing | 169.72M | 42.86M |
| Market Cap | 903.08M |
| Price to Earnings Ratio | -13.31 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.13 |
| Price to Book Ratio | 6.1 |
| Dividend Yield | - |
| Shares Outstanding | 33.7M |
| Average Volume (1 week) | 158.01k |
| Average Volume (1 Month) | 152.36k |
| 52 Week Change | 21.82% |
| 52 Week High | 36.37 |
| 52 Week Low | 14.35 |
| Spread (Intraday) | 5.38 (17.08%) |
| Company Name | ArriVent BioPharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://arrivent.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
